| 摘要 |
FIELD: medicine.SUBSTANCE: invention refers to biotechnology. What is described is a method for predicting an individual's response to a therapeutic agent for treating rheumatoid arthritis (RA). What is also presented is a method for predicting if the individual suffering RA responds to the B-cell antagonist therapy. There are also presented method of predicting if the individual with rheumatoid arthritis responds to the B-cell antagonist therapy effectively and method for selecting the therapy of patients or patients' subpopulation with rheumatoid arthritis. All the methods involves measuring a biological sample prepared from the individual to determine an expression of one gene or a combination thereof or an expression of one protein or a combination thereof coded by one gene or a combination thereof, wherein one gene or a combination thereof are specified in any of CXCL13, FcRH5 and sFcRH5.EFFECT: invention extends the diagnostic capabilities in relation to RA.20 cl, 14 dwg, 13 tbl |
